Brad S Metcalf1,2, Joanne Hosking3, William E Henley4, Alison N Jeffery3, Mohammod Mostazir4, Linda D Voss3, Terence J Wilkin4. 1. Institute of Health Research, University of Exeter Medical School, Exeter, UK. b.metcalf@exeter.ac.uk. 2. Sport and Health Sciences, College of Life and Environmental Sciences, University of Exeter, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK. b.metcalf@exeter.ac.uk. 3. Department of Endocrinology and Metabolism, Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK. 4. Institute of Health Research, University of Exeter Medical School, Exeter, UK.
Abstract
AIMS/HYPOTHESIS: The aim of this work was to test whether the mid-adolescent peak in insulin resistance (IR) and trends in other metabolic markers are influenced by long-term exposure to physical activity. METHODS: Physical activity (7 day ActiGraph accelerometry), HOMA-IR and other metabolic markers (glucose, fasting insulin, HbA1c, lipids and BP) were measured annually from age 9 years to 16 years in 300 children (151 boys) from the EarlyBird study in Plymouth, UK. The activity level of each child was characterised, with 95% reliability, by averaging their eight annual physical activity measures. Age-related trends in IR and metabolic health were analysed by multi-level modelling, with physical activity as the exposure measure (categorical and continuous) and body fat percentage (assessed by dual-energy X-ray absorptiometry) and pubertal status (according to age at peak height velocity and Tanner stage) as covariates. RESULTS: The peak in IR at age 12-13 years was 17% lower (p < 0.001) in the more active adolescents independently of body fat percentage and pubertal status. However, this difference diminished progressively over the next 3 years and had disappeared completely by the age of 16 years (e.g. difference was -14% at 14 years, -8% at 15 years and +1% at 16 years; 'physical activity × age(2), interaction, p < 0.01). Triacylglycerol levels in girls (-9.7%, p = 0.05) and diastolic blood pressure in boys (-1.20 mmHg, p = 0.03) tended to be lower throughout adolescence in the more active group. CONCLUSIONS/ INTERPRETATION: Our finding that physical activity attenuates IR during mid-adolescence may be clinically important. It remains to be established whether the temporary attenuation in IR during this period has implications for the development of diabetes in adolescence and for future metabolic health generally.
AIMS/HYPOTHESIS: The aim of this work was to test whether the mid-adolescent peak in insulin resistance (IR) and trends in other metabolic markers are influenced by long-term exposure to physical activity. METHODS: Physical activity (7 day ActiGraph accelerometry), HOMA-IR and other metabolic markers (glucose, fasting insulin, HbA1c, lipids and BP) were measured annually from age 9 years to 16 years in 300 children (151 boys) from the EarlyBird study in Plymouth, UK. The activity level of each child was characterised, with 95% reliability, by averaging their eight annual physical activity measures. Age-related trends in IR and metabolic health were analysed by multi-level modelling, with physical activity as the exposure measure (categorical and continuous) and body fat percentage (assessed by dual-energy X-ray absorptiometry) and pubertal status (according to age at peak height velocity and Tanner stage) as covariates. RESULTS: The peak in IR at age 12-13 years was 17% lower (p < 0.001) in the more active adolescents independently of body fat percentage and pubertal status. However, this difference diminished progressively over the next 3 years and had disappeared completely by the age of 16 years (e.g. difference was -14% at 14 years, -8% at 15 years and +1% at 16 years; 'physical activity × age(2), interaction, p < 0.01). Triacylglycerol levels in girls (-9.7%, p = 0.05) and diastolic blood pressure in boys (-1.20 mmHg, p = 0.03) tended to be lower throughout adolescence in the more active group. CONCLUSIONS/ INTERPRETATION: Our finding that physical activity attenuates IR during mid-adolescence may be clinically important. It remains to be established whether the temporary attenuation in IR during this period has implications for the development of diabetes in adolescence and for future metabolic health generally.
Authors: Russell Jago; Niels Wedderkopp; Peter L Kristensen; Niels C Møller; Lars B Andersen; Ashley R Cooper; Karsten Froberg Journal: Am J Prev Med Date: 2008-10-09 Impact factor: 5.043
Authors: Alison N Jeffery; Brad S Metcalf; Joanne Hosking; Adam J Streeter; Linda D Voss; Terence J Wilkin Journal: Diabetes Care Date: 2012-01-25 Impact factor: 19.112
Authors: Brad S Metcalf; Alison N Jeffery; Joanne Hosking; Linda D Voss; Naveed Sattar; Terence J Wilkin Journal: Diabetes Care Date: 2008-11-25 Impact factor: 19.112
Authors: Richard D Telford; Ross B Cunningham; Rohan M Telford; Jennifer Kerrigan; Peter E Hickman; Julia M Potter; Walter P Abhayaratna Journal: PLoS One Date: 2012-10-12 Impact factor: 3.240
Authors: Priscila M Nakamura; Grégore I Mielke; Bernardo L Horta; Maria Cecília Assunção; Helen Gonçalves; Ana M B Menezes; Fernando C Barros; Ulf Ekelund; Soren Brage; Fernando C Wehrmeister; Isabel O Oliveira; Pedro C Hallal Journal: J Phys Act Health Date: 2017-02-07
Authors: Emma J Cockcroft; Bert Bond; Craig A Williams; Sam Harris; Sarah R Jackman; Neil Armstrong; Alan R Barker Journal: BMC Sports Sci Med Rehabil Date: 2019-12-09
Authors: Timo A Lakka; Niina Lintu; Juuso Väistö; Anna Viitasalo; Taisa Sallinen; Eero A Haapala; Tuomo T Tompuri; Sonja Soininen; Panu Karjalainen; Theresia M Schnurr; Santtu Mikkonen; Mustafa Atalay; Tuomas O Kilpeläinen; Tomi Laitinen; David E Laaksonen; Kai Savonen; Soren Brage; Ursula Schwab; Jarmo Jääskeläinen; Virpi Lindi; Aino-Maija Eloranta Journal: Diabetologia Date: 2020-08-20 Impact factor: 10.122